MM-093

MM-093 · Merrimack Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MM-093, covering 2007-02-23 to 2008-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of MM-093 to Treat Patients With Uveitis [Phase 2]